What Are the Rationales for Oral Anticoagulants in Patients with Atrial Fibrillation?
Atrial fibrillation (AF) may be paroxysmal or chronic and is found in about 0.4% of the adult population. The prevalence of AF increases with age and is detected in about 15% of normal people over 75 years. Globally, AF increases the relative risk of stroke by six times and is associated with an absolute risk of approximately 5-8% per year. The risk of stroke greatly increases with the associated cardiac disorders (previous myocardial infarction, angina, history of heart failure, left atrial dilatation, left-ventricular dysfunction, mitral calcification, and a history of previous thromboembolism).
Related Questions
- Except in Cases of Atrial Fibrillation, What Are the Theoretical Indications of Oral Anticoagulants in the Prevention of Stroke?
- Is clopidogrel plus aspirin an effective treatment in patients with atrial fibrillation?
- What Are the Rationales for Oral Anticoagulants in Patients with Atrial Fibrillation?
